Nyxoah (NYXH) Cost of Revenue (2025 - 2026)

Nyxoah's quarterly Cost of Revenue came in at $3200.8 in Q1 2026, up 649.49% year-on-year from $427.07 in Q1 2025, and up 649.49% quarter-over-quarter from $427.07 in Q1 2025.

Nyxoah has reported Cost of Revenue for 2 years, with the latest figure at $3200.8 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 940.30 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 2.56 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 540.43 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 548.50 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 64.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 328.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 303.50 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 1.81 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 630.96 Mn
10 Nyxoah 1,248.49 1,248.49 4.26 Mn 3,200.82

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3,200.82
Mar 31, 2026 3,200.82
Mar 31, 2025 427.07
Mar 31, 2025 427.07